AN EVALUATION OF THE ASSOCIATION OF CDKN2B (P15) DNA METHYLATION WITH RESPONSE AND SURVIVAL IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS) TREATED IN THE AZA-001 TRIAL

J. Herman, G. Mufti, K. MacBeth, J. Seymour, P. Fenaux, S. Gore, V. Santini, L. Lucy, C. Beach

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)124 - 124
    Number of pages1
    JournalHaematologica
    Volume95
    Publication statusPublished - 2010

    Cite this